Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3251–3300 of 35122
On April 16, 2025, the Board appointed Howard H. Berman, Ph.D. as a Class III director of the Company, effective at the Effective Time.
In addition, on April 16, 2025, in connection with the Agreement, Franklin Berger informed the Board that he would retire following the end of his current term as a Class I director at the 2027 Annual Meeting.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
In addition, Kevin M. Barry was appointed as a director of the Company immediately following the Effective Time.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
On April 15, 2025, Charles Watts, M.D., a member of the Board of Directors (the “Board”) of Biodesix, Inc. (the “Company”), notified the Company of his intention to resign from his position as a director of the Board and as a member of the Compensation Committee, effective at the conclusion of the Company’s 2025 Annual Meeting of Stockholders on May 20, 2025.
On April 15, 2025, the board of directors (the “Board”) of NewAmsterdam Pharma Company N.V. (the “Company”) appointed Adele Gulfo to serve as a member of the Board.
On April 12, 2025, Lynn Liang notified the Board of Directors (the “Board”) of Health In Tech, Inc., a Nevada corporation (the “Company”) that she is resigning from the Board effective April 18, 2025.
the Board elected William (Chip) Clark as a Class I director
On April 16, 2025, the Board of Directors (the "Board") of LGL Group appointed Vice Admiral Colin J. Kilrain, USN (Ret.), as a director of the Company, effective immediately, to serve until the Company's next annual meeting of stockholders or until his successor is duly elected and qualified.
On April 17, 2025, Waterstone Financial, Inc. (the “Company”), announced today that Michael Hansen has decided to retire as a Director of the Company and its wholly-owned subsidiary WaterStone Bank SSB.
On April 16, 2025 the Board of Directors (the “Board”) of Asana, Inc. (the “Company”) appointed Marc Boroditsky to serve on the Board as a Class I director, effective as of April 16, 2025.
On April 14, 2025, the majority shareholders of the Corporation elected James C. Ford to serve as a member of the Board of Directors of the Corporation, effective May 1, 2025.
On April 2, 2025, the majority shareholder of the THC Therapeutics, Inc. (the "Company"), voted to remove Brandon Romanek from the Board of Directors of the Company. Further, on that same day, the remaining Board of Directors removed Mr. Romanek from any and all positions held at the Company.
On May 16, 2025, the Company appointed Cyril Wallace, the Company’s Chief Executive Officer, to the Company’s board of directors.
On May 14, 2025, the Company appointed Rudolph “Rudd” Bakker, age 59, to the Company’s board of directors.
On April 13, 2025, 374Water Inc. (the “Company”) appointed Stephen Jones to the Company’s Board of Directors, effective April 14, 2025.
On April 16, 2025, Bill Wade was appointed to Goosehead Insurance, Inc.’s (the “Company”) Board of Directors (the “Board”).
On April 16, 2025, Liselotte Hyveled informed the Board of Directors (the “Board”) of TriSalus Life Sciences, Inc. (the “Company”) of her decision to resign from her position as a member of the Board, the Nominating and Corporate Governance Committee of the Board and the Science and Technology Committee of the Board, effective immediately.
On April 10, 2025, Bertrand Loy informed the Company that he will not stand for re-election at the Company’s 2025 Annual Meeting.
The board of directors (the “Board”) of Phathom Pharmaceuticals, Inc. (the “Company”) appointed Theodore R. Schroeder to the Board as a Class I director, effective April 16, 2025
In accordance with the terms of the Merger Agreement, effective upon completion of the Merger, each of Sudhakar Ramakrishna, Cathleen Benko, William Bock, Kenneth Hao, Dennis Howard, Catherine Kinney, Doug Smith, Easwaran Sundaram and Michael Widmann resigned from the Board of Directors of the Company (the “ Board ”) and any committees of the Board on which they served and ceased to be directors of the Company.
In accordance with the terms of the Merger Agreement, effective upon completion of the Merger, each of Sudhakar Ramakrishna, Cathleen Benko, William Bock, Kenneth Hao, Dennis Howard, Catherine Kinney, Doug Smith, Easwaran Sundaram and Michael Widmann resigned from the Board of Directors of the Company (the “ Board ”) and any committees of the Board on which they served and ceased to be directors of the Company.
Also in accordance with the terms of the Merger Agreement, effective upon completion of the Merger the following persons became directors of the Surviving Corporation: Sudhakar Ramakrishna, Dominic Ang, Chase Sorgel, Matt Amico, and Alvin Ang.
In accordance with the terms of the Merger Agreement, effective upon completion of the Merger, each of Sudhakar Ramakrishna, Cathleen Benko, William Bock, Kenneth Hao, Dennis Howard, Catherine Kinney, Doug Smith, Easwaran Sundaram and Michael Widmann resigned from the Board of Directors of the Company (the “ Board ”) and any committees of the Board on which they served and ceased to be directors of the Company.
In accordance with the terms of the Merger Agreement, effective upon completion of the Merger, each of Sudhakar Ramakrishna, Cathleen Benko, William Bock, Kenneth Hao, Dennis Howard, Catherine Kinney, Doug Smith, Easwaran Sundaram and Michael Widmann resigned from the Board of Directors of the Company (the “ Board ”) and any committees of the Board on which they served and ceased to be directors of the Company.
In accordance with the terms of the Merger Agreement, effective upon completion of the Merger, each of Sudhakar Ramakrishna, Cathleen Benko, William Bock, Kenneth Hao, Dennis Howard, Catherine Kinney, Doug Smith, Easwaran Sundaram and Michael Widmann resigned from the Board of Directors of the Company (the “ Board ”) and any committees of the Board on which they served and ceased to be directors of the Company.
In accordance with the terms of the Merger Agreement, effective upon completion of the Merger, each of Sudhakar Ramakrishna, Cathleen Benko, William Bock, Kenneth Hao, Dennis Howard, Catherine Kinney, Doug Smith, Easwaran Sundaram and Michael Widmann resigned from the Board of Directors of the Company (the “ Board ”) and any committees of the Board on which they served and ceased to be directors of the Company.
Also in accordance with the terms of the Merger Agreement, effective upon completion of the Merger the following persons became directors of the Surviving Corporation: Sudhakar Ramakrishna, Dominic Ang, Chase Sorgel, Matt Amico, and Alvin Ang.
Also in accordance with the terms of the Merger Agreement, effective upon completion of the Merger the following persons became directors of the Surviving Corporation: Sudhakar Ramakrishna, Dominic Ang, Chase Sorgel, Matt Amico, and Alvin Ang.
In accordance with the terms of the Merger Agreement, effective upon completion of the Merger, each of Sudhakar Ramakrishna, Cathleen Benko, William Bock, Kenneth Hao, Dennis Howard, Catherine Kinney, Doug Smith, Easwaran Sundaram and Michael Widmann resigned from the Board of Directors of the Company (the “ Board ”) and any committees of the Board on which they served and ceased to be directors of the Company.
Also in accordance with the terms of the Merger Agreement, effective upon completion of the Merger the following persons became directors of the Surviving Corporation: Sudhakar Ramakrishna, Dominic Ang, Chase Sorgel, Matt Amico, and Alvin Ang.
Also in accordance with the terms of the Merger Agreement, effective upon completion of the Merger the following persons became directors of the Surviving Corporation: Sudhakar Ramakrishna, Dominic Ang, Chase Sorgel, Matt Amico, and Alvin Ang.
In accordance with the terms of the Merger Agreement, effective upon completion of the Merger, each of Sudhakar Ramakrishna, Cathleen Benko, William Bock, Kenneth Hao, Dennis Howard, Catherine Kinney, Doug Smith, Easwaran Sundaram and Michael Widmann resigned from the Board of Directors of the Company (the “ Board ”) and any committees of the Board on which they served and ceased to be directors of the Company.
In accordance with the terms of the Merger Agreement, effective upon completion of the Merger, each of Sudhakar Ramakrishna, Cathleen Benko, William Bock, Kenneth Hao, Dennis Howard, Catherine Kinney, Doug Smith, Easwaran Sundaram and Michael Widmann resigned from the Board of Directors of the Company (the “ Board ”) and any committees of the Board on which they served and ceased to be directors of the Company.
Accordingly, as of the Effective Time, Christine R. Detrick, Robert C. Bernard, Robert M. Horn, Richard N. Peretz, Tina C. Reich and Richard A. Shapiro, resigned and ceased serving on the Company’s board of directors and all of its committees.
Accordingly, as of the Effective Time, Christine R. Detrick, Robert C. Bernard, Robert M. Horn, Richard N. Peretz, Tina C. Reich and Richard A. Shapiro, resigned and ceased serving on the Company’s board of directors and all of its committees.
Accordingly, as of the Effective Time, Christine R. Detrick, Robert C. Bernard, Robert M. Horn, Richard N. Peretz, Tina C. Reich and Richard A. Shapiro, resigned and ceased serving on the Company’s board of directors and all of its committees.
Accordingly, as of the Effective Time, Christine R. Detrick, Robert C. Bernard, Robert M. Horn, Richard N. Peretz, Tina C. Reich and Richard A. Shapiro, resigned and ceased serving on the Company’s board of directors and all of its committees.
Accordingly, as of the Effective Time, Christine R. Detrick, Robert C. Bernard, Robert M. Horn, Richard N. Peretz, Tina C. Reich and Richard A. Shapiro, resigned and ceased serving on the Company’s board of directors and all of its committees.
Accordingly, as of the Effective Time, Christine R. Detrick, Robert C. Bernard, Robert M. Horn, Richard N. Peretz, Tina C. Reich and Richard A. Shapiro, resigned and ceased serving on the Company’s board of directors and all of its committees.
On April 11, 2025, the Board of Directors (the “Board”) of NextNav Inc. (the “Company”) increased the size of the Board from seven (7) directors to nine (9) directors and appointed each of Rear Admiral (Ret.) H. Wyman Howard III and Rear Admiral (Ret.) Lorin Selby, as a director to fill the resulting vacancies, effective May 1, 2025.
On April 11, 2025, the Board of Directors (the “Board”) of NextNav Inc. (the “Company”) increased the size of the Board from seven (7) directors to nine (9) directors and appointed each of Rear Admiral (Ret.) H. Wyman Howard III and Rear Admiral (Ret.) Lorin Selby, as a director to fill the resulting vacancies, effective May 1, 2025.
On April 10, 2025, Godfrey Sullivan notified the Board of Directors (the “Board”) of Marqeta, Inc. (the “Company”) of his intent to resign from the Board effective as of the Annual Meeting of Shareholders on June 12, 2025 (the “Annual Meeting”).
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.